Membership and Research Affiliations
Cancer and Leukemia Group B (CALGB)
Founded in 1956, CALGB is a national clinical research group sponsored by the National Cancer Institute (NCI). Its central office is located at the University of Chicago, and its statistical center is located at Duke University. CALGB brings together physicians and laboratory investigators to help develop better treatments for cancer. CALGB has a national network of 26 university medical centers, 200 community hospitals, and 3000 oncology specialists. Their studies aim to reduce morbidity and mortality from cancer, relate biological characteristics of cancer to clinical outcomes, and develop new strategies for the early detection and prevention of cancer.
www.calgb.org
Cancer Therapy Evaluation Program (CTEP)
The mission of the Cancer Therapy Evaluation Program is to improve the lives of cancer patients by finding better ways to treat, control and cure cancer. CTEP accomplishes this mission by funding an extensive national program of cancer research and by sponsoring clinical trials to evaluate new anti-cancer agents, with a particular emphasis on translational research to elucidate molecular targets and mechanisms of drug effects.
www.ctep.info.nih.gov
Cancer Trials Support Unit (CTSU)
The Cancer Trials Support Unit is a project sponsored by the National Cancer Institute (NCI) for the support of a national network of physicians to participate in NCI-sponsored cancer treatment trials. Their objective is to increase physician and patient access to NCI-sponsored clinical trials, streamline and standardize data collection and reporting, and reduce the regulatory burden on investigators participating in NCI-sponsored clinical trials.
www.ctsu.org
Eastern Cooperative Oncology Group (ECOG)
ECOG, established in 1955, was one of the first cooperative groups launched to perform multi-center trials. A cooperative group is a large network of researchers, physicians, and health care professionals at public and private institutions across the country. Funded primarily by the National Cancer Institute (NCI), ECOG is one of the largest research organizations in the United States with almost 6000 physicians, nurses, pharmacists, statisticians, and Clinical Research Associates (CRA). These research teams work toward the common goal of controlling, effectively treating, and ultimately curing cancer.
www.ecog.org
Gynecologic Oncology Group (GOG)
The Gynecologic Oncology Group is a non-profit organization with the purpose of promoting excellence in the quality and integrity of clinical research in the field of Gynecologic malignancies. The Group of gynecologic oncologists, medical oncologists, pathologists, radiation oncologists, nurses, statisticians, basic scientists, quality of life experts, data managers and administrative personnel are committed to maintaining the highest standards in clinical trials development, execution, analysis and distribution of results.
www.gog.org
Mayo Clinic Cancer Research Consortium (MCCRC)
The Mayo Clinic Cancer Research Consortium is a clinical research group based at the Mayo Clinic Cancer Center in Rochester, Minnesota. The MCCRC includes a network of more than 30 community-based cancer treatment clinics and hospitals in the United States and Canada. MCCRC was established in 2004 to conduct pharmaceutical industry-sponsored clinical trials to improve cancer treatment.
mccrc.mayo.edu
North Central Cancer Treatment Group (NCCTG)
The North Central Cancer Treatment Group was founded in 1977 by pioneering physicians from the north central region of the United States and the Mayo Clinic in Rochester, Minn. These physicians saw a need to bring high-quality cancer care and research to the communities where patients live and receive most of their medical care. To achieve this goal, they formed a cancer clinical trials cooperative group. This cooperative group allows promising scientific ideas developed at Mayo Clinic to be tested in many communities throughout the NCCTG network, allowing broad access to the latest therapies.
ncctg.mayo.edu
National Surgical Adjuvant Breast and Bowel Project (NSABP)
The National Surgical Adjuvant Breast and Bowel Project is a clinical trials cooperative group supported since its inception by the National Cancer Institute (NCI). They have a 50-year history of designing and conducting clinical trials that have changed the way breast cancer is treated, and, more recently, prevented. It was the NSABP's breast cancer studies that led to the establishment of lumpectomy plus radiation over radical mastectomy as the standard surgical treatment for breast cancer. They were also the first to demonstrate that adjuvant therapy could alter the natural history of breast cancer, increasing survival rates, and the first to demonstrate on a large scale the preventive effects of the drug Tamoxifen in breast cancer.
www.nsabp.pitt.edu
Southwest Oncology Group (SWOG)
Southwest Oncology Group is one of the largest cancer clinical trials cooperative groups in the United States. Funded largely by research grants from the National Cancer Institute, part of the National Institutes of Health, the Group conducts clinical trials to prevent and treat cancer in adults, and to improve the quality of life for cancer survivors. SWOG studies many adult cancer types, including breast, gastrointestinal, genitourinary, gynecologic, and lung cancers, as well as melanoma, myeloma, leukemia and lymphoma. Approximately 100 clinical trials are underway at any given time.
www.swog.org
